<DOC>
	<DOCNO>NCT02740270</DOCNO>
	<brief_summary>The purpose trial explore clinical utility two investigational antibody patient advance cancer lymphoma . This multi-center , open-label Phase I/Ib study . The study consist two dose escalation part two dose expansion part test GWN323 single agent GWN323 combination PDR001 . The dose escalation part estimate MTD and/or RDE test different dosing schedule . The dose expansion part study use MTD/RDE determine dose escalation part ass activity , safety tolerability investigational product patient specific type cancer lymphoma . Approximately 264 adult patient advance solid tumor lymphomas enrol .</brief_summary>
	<brief_title>Phase I/Ib Study GWN323 Alone Combination With PDR001 Patients With Advanced Malignancies Lymphomas</brief_title>
	<detailed_description />
	<mesh_term>Lymphoma</mesh_term>
	<criteria>Patients metastatic and/or advance solid tumor lymphomas amenable curative treatment surgery . Histologically document advanced metastatic solid tumor lymphomas Must site disease amenable biopsy , candidate tumor biopsy accord treat institution 's guideline . Patient must willing undergo new tumor biopsy screen ECOG Performance Status â‰¤ 2 . Presence symptomatic central nervous system ( CNS ) metastases , CNS metastases require local CNSdirected therapy ( radiotherapy surgery ) . Patients diagnose Tcell Lymphomas . Patients prior allogenic transplant . Patients previously treat antiGITR therapy . History severe hypersensitivity reaction mAbs . Patients intolerant prior immunotherapy ( unable continue/receive due immunerelated AE ) . Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>advanced solid tumor</keyword>
	<keyword>lymphoma</keyword>
	<keyword>GWN323</keyword>
	<keyword>PDR001</keyword>
	<keyword>advanced malignancy</keyword>
	<keyword>anti-GITR</keyword>
	<keyword>anti-PD-1</keyword>
	<keyword>adult</keyword>
</DOC>